Royal Bank Of Canada Edap Tms Sa Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.17 - $8.5 $7,108 - $11,687	-1,375 Reduced 8.4%	15,000 $81,000
Q1 2024 Nov 05, 2024	BUY	$5.1 - $7.78 $7,012 - $10,697	1,375 Added 9.17%	16,375 $120,000
Q3 2023 Nov 14, 2023	SELL	$6.2 - $9.34 $12,400 - $18,680	-2,000 Reduced 10.88%	16,375 $114,000
Q2 2023 Aug 14, 2023	BUY	$8.76 - $11.92 $29,565 - $40,230	3,375 Added 22.5%	18,375 $169,000
Q1 2023 May 15, 2023	BUY	$10.44 - $12.49 $20,880 - $24,980	2,000 Added 15.38%	15,000 $166,000
Q3 2022 Nov 14, 2022	BUY	$6.25 - $8.94 $46,875 - $67,050	7,500 Added 136.36%	13,000 $107,000
Q1 2022 May 16, 2022	BUY	$5.73 - $7.81 $5,730 - $7,810	1,000 Added 22.22%	5,500 $40,000
Q4 2021 Feb 14, 2022	SELL	$5.3 - $6.3 $2,650 - $3,150	-500 Reduced 10.0%	4,500 $27,000
Q2 2021 Aug 16, 2021	BUY	$5.88 - $9.54 $29,400 - $47,699	5,000 New	5,000 $35,000

15.6M

67.6K

60.9K

Ticker EDAP
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,145,300
Market Cap $78.8M
Description
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.